| Seeta Patel, MD | |
|
940 Belmont St, Brockton, MA 02301-5596 | |
| (774) 826-2458 | |
| Not Available |
| Full Name | Seeta Patel |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 940 Belmont St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285998872 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Seeta Patel, MD 919 Winding Ridge Dr, Somerset, KY 42503-6270 Ph: () - | Seeta Patel, MD 940 Belmont St, Brockton, MA 02301-5596 Ph: (774) 826-2458 |
News Archive
An assistant professor of psychology in the School of Science at IUPUI will apply nearly $1 million in recently approved grants to study how a telephone-based treatment process can help ease stress and anxiety issues experienced by advanced-stage lung cancer patients and the family members who care for them.
"Focused ultrasound has the potential to be a game-changing technology that could impact the lives of millions of people with serious medical disorders including essential tremor," says Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation and former Co-Chair of Neurosurgery at the University of Virginia.
Physician-researchers at the University of Southern California (USC) received a nearly $16 million grant from the California Institute of Regenerative Medicine (CIRM) to fund the development of a stem cell-based treatment for age-related macular degeneration, the leading cause of vision loss and blindness among the elderly.
A distinctly new type of methicillin resistant Staphylococcus aureus (MRSA) that is not detected by traditional genetic screening methods has been discovered in patients in Irish hospitals according to research to be published in the journal Antimicrobial Agents and Chemotherapy.
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
› Verified 1 days ago
Demin Ma, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Brockton, MA 02302 Phone: 508-941-7228 Fax: 508-941-6401 | |
Dr. Sharon M Parnes, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 830 Oak St Ste 220e, Brockton, MA 02301 Phone: 508-427-3870 Fax: 617-508-5063 | |
Dr. Sarah Yasmin, M.D., M.P.H Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 940 Belmont Street (116a), Vabhs Mental Health Service, Brockton, MA 02301 Phone: 774-826-2476 Fax: 774-826-3129 | |
Dil Tahera, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 940 Belmont St, Brockton, MA 02301 Phone: 774-826-3151 | |
Anne Ling Li, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 165 Quincy St, Brockton, MA 02302 Phone: 508-897-2000 Fax: 508-897-2223 | |
Elena B Nikolskaia, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 940 Belmont Street, Brockton Va Medical Center, Brockton, MA 02401 Phone: 617-971-3018 | |
Dr. Olga Osokina, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 940 Belmont St, Brockton, MA 02301 Phone: 774-826-2326 |